SAVAVET Launches “Elofi-Pet” at the Annual Meeting of CA Division

SAVAVET CA business successfully conducted its Annual Meeting at Mastiff Grand Sia Palace, bringing together team members from across the country to reflect on achievements, align on future goals, and strengthen collaboration.

A key highlight of the event was the launch of “Elofi-Pet” (Oclacitinib Maleate Tablets) by Mr. Karthik Rajan, CEO of SAVA Healthcare. Developed for the management of allergic and atopic dermatitis in dogs, Elofi-Pet reinforces SAVAVET’s commitment to advancing companion animal healthcare through innovative solutions.

The meeting featured business reviews, strategic discussions, and team engagement activities, setting the foundation for a year of continued growth and success.